https://www.selleckchem.com/pr....oducts/pf-07220060.h
Surgery is the primary treatment for Cushing's disease(CD). In cases with no biochemical remission after surgical resection or when recurrence occurs after a period of remission stereotactic radiosurgery (SRS) is used as alternative/adjuvant treatment. The aim of this study is to demonstrate the effectiveness of SRS and FSRS(Fractionated stereotactic radiosurgery) for the treatment of CD in a long term follow up. This is a retrospective study in which 41 patient (36 females and 5 males) who underwent surgery for CD from 2009 to 2019